The road to market: breaking down the stages of clinical trials for pharmaceutical products
Around the world, pharmaceutical companies conduct clinical trials to evaluate the safety and efficacy of their drugs. These studies are...
Trending:
-
![]()
Could cutting out mediators let cancer research off the leash?
-
![IPF]()
Researchers uncover pathogenic mechanism causing IPF
-
![Symkevi]()
NICE suspends review of Vertex’s Symkevi for cystic fibrosis
-
![Changsheng]()
Results from investigation into Chinese Changsheng’s rabies vaccine scandal unveiled
-
![CGT]()
FDA approves first generic drug under new CGT designation
-
![Spark Therapeutics Q2 financial results]()
Spark Therapeutics Q2 financial results: income growth helped by US launch of Luxturna
Expert commentary & analysis from GlobalData
Pfizer/Lilly’s Phase III trial for tanezumab in osteoarthritis still draws caution
Survey shows pharma’s doubts over Brexit outcome
Achillion’s C3G trial earmarked for success, despite slow recruitment
UK drug stockpiling begins as CMOs complain of Brexit uncertainty
Most Read
Company releases
Adenovirus
SIRION Biotech’s engineered adenovirus vectors are used for transient and quantitative gene expression or knockdown.
Adeno-associated virus (AAV)
NextGenAAV
SIRION Biotech’s NextGenAAV is a full customisation service for gene therapy research and development (R&D). The company can optimise adeno-associated...
BOOST™ Products
Huber Kältemaschinenbau Opens New Subsidiary in China
Peter Huber Kältemaschinenbau has continued its international expansion by opening a new sales office based...
Company whitepapers
Fast and Reliable Quantification of Data
Malvern PanalyticalGT X.ONE – Excellence in Granulation Technology
ACG Associated CapsulesPatch Pump Applications
Weibel CDSNinconex Medical Brochure
Niconex MedicalPharmaceutical Challenges Aided by Laboratory Powder X-ray Diffraction
Malvern PanalyticalThe Secrets of Efficient Combination Product Development
anteris medicalGetting Acquainted with the XRF Theory
Malvern PanalyticalCompany A-Z
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Projects
Amgen’s New Bio-manufacturing Plant, Rhode Island, US
US-based biopharmaceutical company Amgen is developing a bio-manufacturing facility at its campus in West Greenwich, Rhode Island, US.
Chugai Pharmaceutical’s New Synthetic Research Facility, Tokyo
Eisai Centre for Genetics Guided Dementia Discovery, Massachusetts, US
Minakem’s High-Containment Production Facility, Louvain-la-Neuve, Belgium
Boehringer Ingelheim Biologicals Development Centre (BDC), Biberach, Germany
Clinical Trials
Seattle Children’s launches new CAR T-cell immunotherapy trial
US-based Seattle Children’s has initiated a Phase I clinical trial to treat solid tumours using chimeric antigen receptor (CAR) T-cell immunotherapy.
Study shows methylphenidate is most effective ADHD drug for under-16s
MHRA outlines post-Brexit clinical trials regulation
FDA rejects Insys’ opioid spray Buvaya
CStone’s MEK inhibitor approved for trials in China
Drug Development
AI technology to help design personalised combination therapy
A research team led by the National University of Singapore (NUS) has developed an artificial intelligence (AI) platform that can help doctors establish the most...
Bluebird Bio and Regeneron to collaborate on cancer cell therapies
Glenmark partners Harbour BioMed to develop oncology candidate in China
FDA to support development of nicotine replacement therapies
Boehringer forms new alliance to develop gene therapy
Market Data
Deals this week: Pharmaxis, Almirall, Cipla Quality Chemical Industries
Pharmaxis has raised A$24m ($17.74m) in two tranches through a private placement of 73.8 million shares priced at A$0.325 ($0.24) a share.
Spark Therapeutics Q2 financial results: income growth helped by US launch of Luxturna
Mylan Q2 financial results: revenue decline led by falling sales in North America
FDA approves Vertex’s cystic fibrosis therapy Orkambi for children under six
Array BioPharma’s mCRC therapy gets breakthrough status
Technology
AI technology to help design personalised combination therapy
A research team led by the National University of Singapore (NUS) has developed an artificial intelligence (AI) platform that can help doctors establish the most...
UNC develops artificial intelligence system to design new drugs
New UK Health Secretary lays out major priorities for the NHS
Roche and PureTech to develop oral antisense oligonucleotides
Chinese Ping An Good Doctor obtains trade license